Delivery Order SPE2DR25D2014-SPE2DR26FZ73J
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,473.06 to AmerisourceBergen Drug Corp for 100 tablets of Ambien CR 6.25 mg on October 29, 2025. This is a firm fixed-price contract with an ultimate completion date of October 30, 2025, and was awarded competitively with no set-aside designation. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $1,559.10 to AmerisourceBergen Drug Corp for 100 tablets of Ambien CR 6.25 mg. The contract was competitively awarded without a set-aside designation and operates under firm fixed-price terms, with an ultimate completion date of November 7, 2025. Performance will occur at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $4,118.84 delivery order to AmerisourceBergen Drug Corp for 100 tablets of Ambien CR 6.25 mg on July 22, 2025, with ultimate completion scheduled for July 23, 2025. This contract utilizes firm fixed pricing and carries no set-aside designation, reflecting a competitively awarded transaction. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,441.94 to AmerisourceBergen Drug Corp for the supply of Ambien CR 6.25 mg tablets (100-count packages) on August 27, 2025, with an ultimate completion date of August 28, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,584.42 to AmerisourceBergen Drug Corp for 100 tablets of Ambien CR 6.25 mg, with performance in Conshohocken, Pennsylvania and a completion date of September 29, 2025. This non-set-aside contract was competitively awarded under firm fixed-price terms as a delivery order, reflecting standard pharmaceutical procurement practices within the federal medical supply chain. AmerisourceBergen Drug Corp, headquartered in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,660.27 to AmerisourceBergen Drug Corp for 100 tablets of Ambien CR 6.25 mg, with an ultimate completion date of September 12, 2025. This competitive, firm fixed-price delivery order was issued under no set-aside designation. The prime contractor, AmerisourceBergen Drug Corp, is headquartered in Conshohocken, Pennsylvania, and serves as a major pharmaceutical distributor for federal medical procurement, particularly...
- The Defense Logistics Agency awarded a delivery order valued at $7,563.72 to AmerisourceBergen Drug Corp for 100 tablets of Ambien CR 6.25 mg, with performance scheduled for completion by September 29, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, regularly supplies...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,525.66 to AmerisourceBergen Drug Corp for 100 tablets of Ambien CR 6.25 mg, with an ultimate completion date of November 14, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being fulfilled from the vendor's place of performance in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $1,416.21 to AmerisourceBergen Drug Corp for 100 tablets of Ambien CR 6.25 mg. This competitive, non-set-aside contract carries a firm fixed price and is scheduled for completion by November 6, 2025. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a $2,179.40 delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Ambien CR 6.25 mg tablets in quantities of 100. This firm fixed price, competitively awarded contract with no set-aside designation is scheduled for completion by July 15, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's existing...
- SPE2DR25D2014Indefinite Delivery Contract
- SPE2DR25D2014-SPE2DR26FZ73JDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,149.57 to AmerisourceBergen Drug Corp for 100 tablets of Ambien CR 6.25 mg, with an ultimate completion date of November 18, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and specifies Conshohocken, Pennsylvania as the place of performance, which is also the vendor's corporate headquarters location. AmerisourceBergen Drug Corp serves as a major pharmaceutical distributor and critical supplier to federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA's Medical Supply Chain. This delivery order represents a single transaction under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive global pharmaceutical support vehicle running through December 2026. The parent contract enables the company to supply a broad range of pharmaceutical products and medical supplies supporting military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen Drug Corp competes in the open market for these awards, demonstrating its capability to meet federal pharmaceutical procurement requirements across multiple therapeutic domains and transaction sizes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 11/17/25 |